SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andriy Turhovach who wrote (235)4/22/2003 4:11:36 PM
From: Biomaven  Read Replies (1) of 4232
 
Thanks.

Here's the money paragraph for any potential biotech longs:

These are 16 AIDS drugs, 13 herpes drugs and seven aimed at flu and other viruses. Also to be tested are seven forms of interferon, which are the body's natural microbe killers.

"Certainly there isn't an upfront rational reason to think any of those would work," she said. "But if any of them did, it would be extremely valuable, because they are available and understood."

The best chance of success may be with about 30 drugs not yet approved but already in testing for other purposes. All are aimed at viral processes similar to those in the coronavirus. These include drugs that may prevent the virus from sticking to human cells or that block some of the steps the virus takes to copy itself.


I would guess the chance of an AIDS drug working is pretty remote. The interferons are anybody's guess. The neuraminidase inhibitors ('flu drugs) have to be a very long shot, although I have seen "neuraminidase" and "coronavirus" appear in the same abstract. <g>

Maybe Rick (or someone else) can comment on the alleged 30 drugs being developed to block viral processes. I personally haven't heard of anything directed against a coronavirus.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext